Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
SLC-related prognostic signatures can be utilized for the prognostic evaluation of osteosarcoma. Pharmacological inhibition of SLC7A1 may be a feasible therapeutic approach for osteosarcoma.
Authors
- Junkai Chen (ORCID: https://orcid.org/0000-0001-6903-9390)
- X. Sunney Xie
- Wei‐Dong Chen
- Zhen Guo (ORCID: https://orcid.org/0000-0003-4875-5149)
- Hao Yao (ORCID: https://orcid.org/0000-0002-9704-0505)
- Ting Zheng (ORCID: https://orcid.org/0000-0003-4310-2405)
- Jian Tu (ORCID: https://orcid.org/0009-0005-3988-3917)
- Lili Wen
- Yan Liao
- Yutong Zou (ORCID: https://orcid.org/0000-0001-5750-5286)
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Twelfth Guangzhou City People's Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1186/s12967-025-06086-1
- Citations
- 4
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- National Natural Science Foundation of China